These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21536645)

  • 61. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.
    Lacut K; Le Gal G; Seizeur R; Prat G; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Jun; 21(3):327-33. PubMed ID: 17521302
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk of postprocedural intracerebral hemorrhage in patients with ruptured cerebral aneurysms after treatment with antiplatelet agents.
    Albanna W; Merkelbach L; Schubert GA; Stoppe C; Heussen N; Riabikin A; Wiesmann M; Blume C; Jablawi F; Schiefer J; Clusmann H; Neuloh G
    J Neurol Sci; 2021 Jan; 420():117219. PubMed ID: 33162063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Letter by Schlachetzki et al regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
    Bogdahn U; Schlachetzki F; Schuierer G
    Stroke; 2013 Sep; 44(9):e112. PubMed ID: 23929750
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis.
    Sun C; Song B; Jiang C; Zou JJ
    Expert Rev Neurother; 2019 Apr; 19(4):349-358. PubMed ID: 30807235
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds.
    Imaizumi T; Inamura S; Kohama I; Yoshifuji K; Nomura T; Komatsu K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):869-75. PubMed ID: 22959109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Timing of Antiplatelet Resumption After Intracerebral Hemorrhage: A Sophie's Choice.
    Balali P; Katsanos AH; Shoamanesh A
    Stroke; 2023 Feb; 54(2):546-548. PubMed ID: 36621821
    [No Abstract]   [Full Text] [Related]  

  • 67. Former antiplatelet drug administration and consequences of intravenous thrombolysis in acute ischemic stroke.
    Khazaei M; Davoodian A; Taheri M; Ghafouri-Fard S
    Hum Antibodies; 2020; 28(1):53-56. PubMed ID: 31356199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.
    Moussouttas M; Malhotra R; Fernandez L; Maltenfort M; Holowecki M; Delgado J; Lawson N; Badjatia N
    Neurocrit Care; 2010 Feb; 12(1):24-9. PubMed ID: 19844810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantity of Cerebral Microbleeds, Antiplatelet Therapy, and Intracerebral Hemorrhage Outcomes: A Systematic Review and Meta-analysis.
    Wang DN; Hou XW; Yang BW; Lin Y; Shi JP; Wang N
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2728-37. PubMed ID: 26342996
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy.
    Franco L; Paciaroni M; Enrico ML; Scoditti U; Guideri F; Chiti A; De Vito A; Terruso V; Consoli D; Vanni S; Giossi A; Manina G; Nitti C; Re R; Sacco S; Cappelli R; Beyer-Westendorf J; Pomero F; Agnelli G; Becattini C
    Eur J Intern Med; 2020 May; 75():35-43. PubMed ID: 31955918
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage.
    Roquer J; Vivanco Hidalgo RM; Ois A; Rodríguez Campello A; Cuadrado Godia E; Giralt Steinhauer E; Gómez González A; Soriano-Tarraga C; Jiménez Conde J
    Neurology; 2017 Feb; 88(9):885-891. PubMed ID: 28148636
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.
    Roquer J; Rodríguez Campello A; Gomis M; Ois A; Puente V; Munteis E
    J Neurol; 2005 Apr; 252(4):412-6. PubMed ID: 15739042
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies.
    Keir SL; Wardlaw JM; Sandercock PA; Chen Z
    Cerebrovasc Dis; 2002; 14(3-4):197-206. PubMed ID: 12403952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cerebral microbleeds in patients with intracerebral hemorrhage are associated with previous cerebrovascular diseases and white matter hyperintensity, but not with regular use of antiplatelet agents.
    Nishikawa T; Ueba T; Kajiwara M; Miyamatsu N; Yamashita K
    Neurol Med Chir (Tokyo); 2009 Aug; 49(8):333-8; discussion 338-9. PubMed ID: 19706998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Stroke and intracerebral hemorrhage under anticoagulation or platelet inhibition-when should treatment be restarted and how?].
    Röther J
    Internist (Berl); 2020 Apr; 61(4):424-430. PubMed ID: 32162010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intracerebral hemorrhage after external ventricular drain placement: an evaluation of risk factors for post-procedural hemorrhagic complications.
    Rowe AS; Rinehart DR; Lezatte S; Langdon JR
    BMC Neurol; 2018 Mar; 18(1):22. PubMed ID: 29514640
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation between antiplatelet therapy in secondary prevention of acute cerebral infarction and cerebral microbleeds: A susceptibility-weighted imaging (SWI) study.
    Jia C; Wei C; Hu M; Xu J; Niu K; Zhang C; Lv P; Li L; Dong Y
    J Xray Sci Technol; 2018; 26(4):623-633. PubMed ID: 29562586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Multiple cerebral haemorrhages and antiplatelet drugs].
    Rubí-Callejón J; Arjona A; Serrano-Castro PJ
    Rev Neurol; 2004 Sep 16-30; 39(6):600; author reply 600. PubMed ID: 15468007
    [No Abstract]   [Full Text] [Related]  

  • 80. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.